PRESS RELEASES

December 12, 2023 - Cava Healthcare announces publication of three preclinical studies on the effect of curcuphenol compounds in increasing immune destruction of metastatic cancers (read more)

December 4, 2023 - Cava Healthcare announces Intention to Grant Notification from the European Patent Organization for Alzheimer's disease drugs (read more)

November 28, 2023 - Cava Healthcare announces issuance of Canadian Patent on curcuphenol compounds for increasing immune destruction of metastatic cancers (read more)

November 27, 2023 - Cava Healthcare announces results of Annual General Meeting of Shareholders (read more)

November 20, 2023 - Cava Healthcare announces notification of patent allowance from United States Patent and Trademark Office for a new class of Alzheimer's disease drugs (read more)

October 27, 2023 - Cava Healthcare announces non-binding LOI to enable merger with MYND Life Sciences Inc. (read more)

September 12, 2023 - Cava Healthcare announces a proprietary method for rapidly discovering anti-cancer drugs (read more)

March 1, 2023 - Cava Healthcare closes previously announced private placement and announces additional $450,000 private placement (read more)

January 05, 2023 - Cava Healthcare Inc. amends the terms of and closes previously announced private placements (read more)

October 21, 2022 - Cava Healthcare Inc. announces results of Annual General and Special Meeting of Shareholders (read more)

October 13, 2022 - Cava Healthcare Inc. announces revocation of Cease Trade Order (read more)

December 20, 2021 - Cava Healthcare Inc. announces appointments of Jamie Kirwin as Board Director, Lee Girardo to Advisory Committee (read more)

November 1, 2021 - Cava Healthcare Inc. announces publication of Alzheimer's disease research in The Lancet (read more)

- Also see - EurekAlert / AAAS: Cancer chemotherapy drug reverses Alzheimer's symptoms in mice (University of British Columbia, October 5, 2021) (read more)

October 28, 2021 - Cava Healthcare Inc. announces sale of its patented "Use of Psychedelics to treat Dementia" technology (read more)

July 31, 2020 - Cava Healthcare Inc. announces appointment of Greenlight Innovation Partners, $750,000 Private Placement, and closing of 1st tranche of Private Placement (read more)

June 24, 2020 - Cava Healthcare Inc. appoints Theo Warkentin as Director and Chief Executive Officer (read more)

May 5, 2020 - Cava Healthcare Inc. announces closing of 2nd and final tranche of Private Placement (read more)

April 20, 2020 - Cava Healthcare Inc. announces closing of 1st tranche of Private Placement (read more)

March 27, 2020 - Cava Healthcare Inc. announces $300,000 Private Placement (read more)

March 13, 2020 - Cava Healthcare Inc. announces share issuances, settlement with former Officer, issuance of Promisory Note and assignment of non-core assets (read more)

February 3, 2020 - Cava Healthcare Inc. successfully completes its 2020 Annual Meeting and announces the additions of Roslyn Ritchie-Derrien, Terry Pearson, Leigh Anderson and Bill Vander Zalm to the Board of Directors (read more)

January 24, 2020 - Cava Healthcare Inc. announces closing of 2nd tranche of oversubscribed private placement (read more)

December 31, 2019 - Cava Healthcare Inc. announces completion of Share Consolidation and closing of 1st tranche of Private Placement (read more)

December 24, 2019 - Cava Healthcare Inc. announces Share Consolidation and announces $250,000 Private Placement (read more)

December 10, 2019 - Cava Healthcare Inc. announces adoption of Advance Notice Policy - Announces Annual General and Special Meeting - Provides Management Update (read more)

October 16, 2019 - Cava Healthcare Inc. announces Mr. Peter Field as President and Chief Executive Officer and Ms. Tammy Gillis as Corporate Secretary (read more)

October 11, 2019 - Cava Healthcare Inc. announces Close of First Tranche of Private Placement (read more)

August 19, 2019 - Cava Healthcare Inc. announces Peter Field as Director and Tammy Gillis as Chief Financial Officer (CFO) and Adrian Wade as Chief Operating Officer (COO) (read more)

July 25, 2019 - Cava Healthcare Inc. announces Appointment of Dr. N. Leigh Anderson and Dr. Terry Pearson as Founder Members of its Scientific Advisory Committee (read more)

July 09, 2019 - Cava Healthcare Inc. announces the Acquisition of a Portfolio of Patents and the Opening of a Private Placement (read more)

June 27, 2019 - Cava Healthcare Inc. announces a Name Change and Change in the Company's Officers and Directors (read more)